Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker INM
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Nov 5, 2026 | ADAR1 Capital Management, LLC 10% owner | MTRI InMed Pharmaceuticals Inc. | Buy | 2,640 | $13.10 | $34.6K Buy | Form 4 ↗ |
| Oct 23, 2026 | ADAR1 Capital Management, LLC 10% owner | INM InMed Pharmaceuticals Inc. | Buy | 4 | $1.32 | $5.28 Buy | Form 4 ↗ |
| Oct 19, 2026 | ADAR1 Capital Management, LLC 10% owner | INM InMed Pharmaceuticals Inc. | Buy | 1,086 | $1.32 | $1,434 Buy | Form 4 ↗ |
| Oct 16, 2026 | ADAR1 Capital Management, LLC 10% owner | INM InMed Pharmaceuticals Inc. | Buy | 1 | $1.32 | $1.32 Buy | Form 4 ↗ |
| Sep 16, 2026 | Daniel Schneeberger 10% owner | INM InMed Pharmaceuticals Inc. | Buy | 8,340 | $1.29 | $10.8K Buy | Form 4 ↗ |
| Sep 15, 2026 | Daniel Schneeberger 10% owner | INM InMed Pharmaceuticals Inc. | Buy | 54,256 | $1.30 | $70.5K Buy | Form 4 ↗ |
| Sep 14, 2026 | Daniel Schneeberger 10% owner | INM InMed Pharmaceuticals Inc. | Buy | 28,505 | $1.29 | $36.8K Buy | Form 4 ↗ |
| Jul 16, 2026 | Vivo Opportunity Cayman Fund, L.P. 10% owner | INM InMed Pharmaceuticals Inc. | Buy | 2 | $1.55 | $3.1 Buy | Form 4 ↗ |
| Jul 16, 2026 | Vivo Opportunity Cayman Fund, L.P. 10% owner | INM InMed Pharmaceuticals Inc. | Buy | 19 | $1.55 | $29.45 Buy | Form 4 ↗ |
| Jul 15, 2026 | ADAR1 Capital Management, LLC 10% owner | INM InMed Pharmaceuticals Inc. | Buy | 1,000 | $1.56 | $1,560 Buy | Form 4 ↗ |
| Jul 15, 2026 | Vivo Opportunity Cayman Fund, L.P. 10% owner | INM InMed Pharmaceuticals Inc. | Buy | 1,389 | $1.55 | $2,153 Buy | Form 4 ↗ |
| Jul 15, 2026 | Vivo Opportunity Cayman Fund, L.P. 10% owner | INM InMed Pharmaceuticals Inc. | Buy | 13,761 | $1.55 | $21.3K Buy | Form 4 ↗ |
| Jul 14, 2026 | Vivo Opportunity Cayman Fund, L.P. 10% owner | INM InMed Pharmaceuticals Inc. | Buy | 493 | $1.55 | $764 Buy | Form 4 ↗ |
| Jul 14, 2026 | Vivo Opportunity Cayman Fund, L.P. 10% owner | INM InMed Pharmaceuticals Inc. | Buy | 4,882 | $1.55 | $7,567 Buy | Form 4 ↗ |
| Jul 2, 2026 | Vivo Opportunity, LLC 10% owner | INM InMed Pharmaceuticals Inc. | Buy | 147 | $1.55 | $228 Buy | Form 4 ↗ |
| Jul 2, 2026 | Vivo Opportunity, LLC 10% owner | INM InMed Pharmaceuticals Inc. | Buy | 1,460 | $1.55 | $2,263 Buy | Form 4 ↗ |
| Jul 1, 2026 | Vivo Opportunity, LLC 10% owner | INM InMed Pharmaceuticals Inc. | Buy | 398 | $1.55 | $617 Buy | Form 4 ↗ |
| Jul 1, 2026 | Vivo Opportunity, LLC 10% owner | INM InMed Pharmaceuticals Inc. | Buy | 3,946 | $1.55 | $6,116 Buy | Form 4 ↗ |
| Jun 30, 2026 | Vivo Opportunity, LLC 10% owner | INM InMed Pharmaceuticals Inc. | Buy | 55 | $1.54 | $84.7 Buy | Form 4 ↗ |
| Jun 30, 2026 | Vivo Opportunity, LLC 10% owner | INM InMed Pharmaceuticals Inc. | Buy | 545 | $1.54 | $839 Buy | Form 4 ↗ |
| Jun 8, 2026 | Vivo Opportunity, LLC 10% owner | INM InMed Pharmaceuticals Inc. | Buy | 2,982 | $1.52 | $4,533 Buy | Form 4 ↗ |
| Jun 8, 2026 | Vivo Opportunity, LLC 10% owner | INM InMed Pharmaceuticals Inc. | Buy | 29,518 | $1.52 | $44.9K Buy | Form 4 ↗ |
| Jun 5, 2026 | Vivo Opportunity, LLC 10% owner | INM InMed Pharmaceuticals Inc. | Buy | 5,045 | $1.57 | $7,921 Buy | Form 4 ↗ |
| Jun 5, 2026 | Vivo Opportunity, LLC 10% owner | INM InMed Pharmaceuticals Inc. | Buy | 49,966 | $1.57 | $78.4K Buy | Form 4 ↗ |
| Jun 4, 2026 | Vivo Opportunity, LLC 10% owner | INM InMed Pharmaceuticals Inc. | Buy | 618 | $1.57 | $970 Buy | Form 4 ↗ |
| Jun 4, 2026 | Vivo Opportunity, LLC 10% owner | INM InMed Pharmaceuticals Inc. | Buy | 6,125 | $1.57 | $9,616 Buy | Form 4 ↗ |
| Jun 3, 2026 | Vivo Opportunity, LLC 10% owner | INM InMed Pharmaceuticals Inc. | Buy | 714 | $1.55 | $1,107 Buy | Form 4 ↗ |
| Jun 3, 2026 | Vivo Opportunity, LLC 10% owner | INM InMed Pharmaceuticals Inc. | Buy | 7,069 | $1.55 | $11.0K Buy | Form 4 ↗ |
| Jun 2, 2026 | Vivo Opportunity, LLC 10% owner | INM InMed Pharmaceuticals Inc. | Buy | 2,095 | $1.52 | $3,184 Buy | Form 4 ↗ |
| Jun 2, 2026 | Vivo Opportunity, LLC 10% owner | INM InMed Pharmaceuticals Inc. | Buy | 20,753 | $1.52 | $31.5K Buy | Form 4 ↗ |
| Jun 1, 2026 | Vivo Opportunity, LLC 10% owner | INM InMed Pharmaceuticals Inc. | Buy | 1,498 | $1.55 | $2,322 Buy | Form 4 ↗ |
| Jun 1, 2026 | Vivo Opportunity, LLC 10% owner | INM InMed Pharmaceuticals Inc. | Buy | 14,838 | $1.55 | $23.0K Buy | Form 4 ↗ |
| May 29, 2026 | Vivo Opportunity, LLC 10% owner | INM InMed Pharmaceuticals Inc. | Buy | 1,632 | $1.57 | $2,562 Buy | Form 4 ↗ |
| May 29, 2026 | Vivo Opportunity, LLC 10% owner | INM InMed Pharmaceuticals Inc. | Buy | 16,164 | $1.57 | $25.4K Buy | Form 4 ↗ |
| May 21, 2026 | Vivo Opportunity, LLC 10% owner | INM InMed Pharmaceuticals Inc. | Buy | 3,118 | $1.69 | $5,269 Buy | Form 4 ↗ |
| May 21, 2026 | Vivo Opportunity, LLC 10% owner | INM InMed Pharmaceuticals Inc. | Buy | 30,882 | $1.69 | $52.2K Buy | Form 4 ↗ |
| May 20, 2026 | Vivo Opportunity, LLC 10% owner | INM InMed Pharmaceuticals Inc. | Buy | 5,154 | $1.56 | $8,040 Buy | Form 4 ↗ |
| May 20, 2026 | Vivo Opportunity, LLC 10% owner | INM InMed Pharmaceuticals Inc. | Buy | 51,056 | $1.56 | $79.6K Buy | Form 4 ↗ |
| May 19, 2026 | Daniel Schneeberger 10% owner | INM InMed Pharmaceuticals Inc. | Buy | 200,000 | $1.50 | $300.0K Buy | Form 4 ↗ |
| May 19, 2026 | Daniel Schneeberger 10% owner | INM InMed Pharmaceuticals Inc. | Buy | 200,000 | $1.56 | $312.0K Buy | Form 4 ↗ |
| May 19, 2026 | Daniel Schneeberger 10% owner | INM InMed Pharmaceuticals Inc. | Buy | 68,551 | $1.60 | $109.7K Buy | Form 4 ↗ |
41 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 5:46 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances